Evaluating only Dawaa Dost’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Competition.
Key Events Timeline
FOUNDING
Dawaa Dost founded in Delhi by Vivek Rungta to disrupt pharmaceutical B2B distribution.
FUNDING
Raised ₹120 crore to expand to 50+ cities and add medical devices to catalogue.
FRAUD EXPOSURE
Warehouse fraud incidents across three cities caused ₹20 crore in inventory losses.
SHUTDOWN
Filed for bankruptcy with ₹85 crore in liabilities after Series C process collapsed.
Full Analysis
Free · no account needed
Documented cause
Dawaa Dost raised ₹200 crore ($24M) to build a B2B pharmaceutical and medical supply marketplace serving small chemist shops and clinics across India. The company expanded to 50+ cities by 2022 but faced margin compression from established distributors like Medline and Mahindra Logistics. A series of warehouse fraud incidents in 2022 damaged supplier trust. Founder Vivek Rungta was unable to secure Series C funding and the company filed for bankruptcy in December 2023 with liabilities of ₹85 crore.
Lesson
“Pharma distribution fraud risk requires robust inventory controls before geographic expansion.”